NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo

NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo

Yuhui Hua,1 Weijia Wang,1 Xiaoli Zheng,2 Ling Yang,2 Hongjin Wu,2 Zhaoyang Hu,2 Ying Li,2 Jing Yue,2 Zhenzhen Jiang,2 Xiaoyan Zhang,2 Qiang Hou,2 Shixiu Wu3 1Department of Pharmacy, Hangzhou Cancer Hospital, Hangzhou 310002, People’s Republic of China; 2Hangzhou Cancer Institution, Hangzho...

Full description

Bibliographic Details
Main Authors: Hua Y, Wang W, Zheng X, Yang L, Wu H, Hu Z, Li Y, Yue J, Jiang Z, Zhang X, Hou Q, Wu S
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Drug Design, Development and Therapy
Subjects:
escc
radioresistance
jak2
nvp-bsk805
dna damage repair
Online Access:https://www.dovepress.com/nvp-bsk805-an-inhibitor-of-jak2-kinase-significantly-enhances-the-radi-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/nvp-bsk805-an-inhibitor-of-jak2-kinase-significantly-enhances-the-radi-peer-reviewed-article-DDDT

Similar Items